Faculty profile

Jocelyn Dupuis

Back to faculty

ProfessorDépartement de médecineUniversité de Montréal

Jocelyn Dupuis

Professor

Département de médecine

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
12 publications in the last five years, latest in 2025.
Principal investigator on 2 research grants (1 FRQS, 1 CIHR), most recently in 2018.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

2,549

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université de Montréal profile.

Latest papers

Insights into heart failure metabolite markers through explainable machine learning.
Computational and structural biotechnology journal · 2025
Binding of Hypoxia-Induced Mitogenic Factor/RELM-β to Bone Morphogenetic Protein Receptor 2 Complex Promotes Pulmonary Hypertension.
Arteriosclerosis, thrombosis, and vascular biology · 2025
Au-modified ceria nanozyme prevents and treats hypoxia-induced pulmonary hypertension with greatly improved enzymatic activity and safety.
Journal of nanobiotechnology · 2024

All 75 publications

Latest funding

Recherches sur les maladies cardiovasculaires
FRQS · 2018 · Principal investigator
$249,301
Diminuer les facteurs de risque cardiaque par une approche de TRANSITion hôpital-domicile
CIHR · 2010 · Co-investigator
$90,000
Role of Osteopontin and Aldosterone on Lung Structural Remodeling and Right Ventricular Function in Congestive Heart Failure
CIHR · 2009 · Nominated PI
$376,152

All 3 grants and awards

75 publications.

Insights into heart failure metabolite markers through explainable machine learning.

Baron C, Mehanna P, Daneault C, Hausermann L, Busseuil D, Tardif JC, Dupuis J, Des Rosiers C, Ruiz M, Hussin JG

Computational and structural biotechnology journal20257 citationsOpen Access

DOI: 10.1016/j.csbj.2025.02.041 PMID: 40160858

Binding of Hypoxia-Induced Mitogenic Factor/RELM-β to Bone Morphogenetic Protein Receptor 2 Complex Promotes Pulmonary Hypertension.

Zhang T, Zhu L, Liu B, Liu J, Zeng X, Yang W, Ruiz M, Dupuis J, Xiao R, Hu Q

Arteriosclerosis, thrombosis, and vascular biology2025

DOI: 10.1161/atvbaha.125.322652 PMID: 40772295

Au-modified ceria nanozyme prevents and treats hypoxia-induced pulmonary hypertension with greatly improved enzymatic activity and safety.

Xiao R, Liu J, Shi L, Zhang T, Liu J, Qiu S, Ruiz M, Dupuis J, Zhu L, Wang L, Wang Z, Hu Q

Journal of nanobiotechnology202415 citationsOpen Access

DOI: 10.1186/s12951-024-02738-4 PMID: 39160624

Identification of Noncoding Functional Regulatory Variants of STIM1 Gene in Idiopathic Pulmonary Arterial Hypertension.

Liu B, Wen CJ, Zhou G, Wei YP, Wu Z, Zhang T, Zhou Y, Qiu S, Wang T, Ruiz M, Dupuis J, Yuan P, Liu J, Zhu L, Jing ZC, Hu Q

Hypertension (Dallas, Tex. : 1979)20242 citations

DOI: 10.1161/hypertensionaha.124.22766 PMID: 38989583

Extracellular vesicles in venous thromboembolism and pulmonary hypertension.

Zhang J, Hu X, Wang T, Xiao R, Zhu L, Ruiz M, Dupuis J, Hu Q

Journal of nanobiotechnology202315 citationsOpen Access

DOI: 10.1186/s12951-023-02216-3 PMID: 38037042

Co-profiling reveals distinct patterns of genomic chromatin accessibility and gene expression in pulmonary hypertension caused by chronic hypoxia.

Yu D, Zhang T, Zhou G, Wu Z, Xiao R, Zhang H, Liu B, Li X, Ruiz M, Dupuis J, Zhu L, Hu Q

Respiratory research20233 citationsOpen Access

DOI: 10.1186/s12931-023-02389-3 PMID: 37031175

MiR-1249 on Endothelial Extracellular Vesicles Mediates Cigarette Smoke-Induced Pulmonary Hypertension by Inhibiting HDAC10 (Histone Deacetylase 10)-NFκB (Nuclear Factor κB)-CaSR (Calcium-Sensing Receptor) Cascade.

Su Y, Tan R, Sun M, Yuan L, Ruiz M, Dupuis J, Hu Q, Zhu L

Hypertension (Dallas, Tex. : 1979)202225 citationsOpen Access

DOI: 10.1161/hypertensionaha.122.19560 PMID: 36252137

Calcium Sensing Receptor Variants Increase Pulmonary Hypertension Susceptibility.

Liu B, Wei YP, Fan X, Hu X, Chen Z, Liu X, Xu Y, Wang L, Wang T, Ruiz M, Dupuis J, Yuan P, Liu J, Huang S, Zhu L, Jing ZC, Hu Q

Hypertension (Dallas, Tex. : 1979)202218 citationsOpen Access

DOI: 10.1161/hypertensionaha.121.18399 PMID: 35477244

Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study.

Dupuis J, Laurin P, Tardif JC, Hausermann L, Rosa C, Guertin MC, Thibaudeau K, Gagnon L, Cesari F, Robitaille M, Moran JE

Evidence-based complementary and alternative medicine : eCAM202216 citationsFirst authorOpen Access

DOI: 10.1155/2022/3125662 PMID: 36387348

Orally-administrated mitochondria attenuate pulmonary hypertension with the aid of erythrocytes as carriers.

Xiao R, Liu J, Luo S, Yu Z, Zhang J, Lv Y, Li J, Ruiz M, Dupuis J, Hu Q, Zhu L

Clinical and translational medicine20227 citationsOpen Access

DOI: 10.1002/ctm2.1033 PMID: 36149749

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Jocelyn Dupuis

Research

Latest papers

Latest funding

Insights into heart failure metabolite markers through explainable machine learning.

Binding of Hypoxia-Induced Mitogenic Factor/RELM-&#x3b2; to Bone Morphogenetic Protein Receptor 2 Complex Promotes Pulmonary Hypertension.

Au-modified ceria nanozyme prevents and treats hypoxia-induced pulmonary hypertension with greatly improved enzymatic activity and safety.

Identification of Noncoding Functional Regulatory Variants of STIM1 Gene in Idiopathic Pulmonary Arterial Hypertension.

Extracellular vesicles in venous thromboembolism and pulmonary hypertension.

Co-profiling reveals distinct patterns of genomic chromatin accessibility and gene expression in pulmonary hypertension caused by chronic hypoxia.

MiR-1249 on Endothelial Extracellular Vesicles Mediates Cigarette Smoke-Induced Pulmonary Hypertension by Inhibiting HDAC10 (Histone Deacetylase 10)-NF&#x3ba;B (Nuclear Factor &#x3ba;B)-CaSR (Calcium-Sensing Receptor) Cascade.

Calcium Sensing Receptor Variants Increase Pulmonary Hypertension Susceptibility.

Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study.

Orally-administrated mitochondria attenuate pulmonary hypertension with the aid of erythrocytes as carriers.

Recherches sur les maladies cardiovasculaires

Diminuer les facteurs de risque cardiaque par une approche de TRANSITion hôpital-domicile

Role of Osteopontin and Aldosterone on Lung Structural Remodeling and Right Ventricular Function in Congestive Heart Failure

Frequent collaborators

Matthieu Ruiz

Jean-Claude Tardif

Alain Fournier

Éric Thorin

Alexandre Caron

Sylvie Cossette

Paul Khairy

Anique Ducharme

André Denault

Simon Bacon

Kim Lavoie

Martin Sirois

José Côté

Jean-François Tanguay

Jonathan Ledoux

Jie Liu

Jean-François Tremblay

Michel White

Bernard Thibault

Jennifer Gordon

Jean DaSilva

Louis Perrault

Emmanuelle Brochiero

Eileen O'Meara

Marie-Claude Parent

Denyse Gautrin

Tanya Mailhot

Christine Henri

Laurent Macle

Binding of Hypoxia-Induced Mitogenic Factor/RELM-β to Bone Morphogenetic Protein Receptor 2 Complex Promotes Pulmonary Hypertension.

MiR-1249 on Endothelial Extracellular Vesicles Mediates Cigarette Smoke-Induced Pulmonary Hypertension by Inhibiting HDAC10 (Histone Deacetylase 10)-NFκB (Nuclear Factor κB)-CaSR (Calcium-Sensing Receptor) Cascade.